After pediatric heart transplant, commitment to lifelong immunosuppression is crucial to
maintaining graft health. However, a review of the current literature surrounding adherence …

Background Heart transplantation has become the standard of care for pediatric patients
with end‐stage heart disease, and outcomes have consistently improved over the last few …

Heart transplantation has become the standard of care for pediatric patients with end‐stage
heart disease throughout the world. Since the first transplant was performed in 1967, the …

Background Endomyocardial biopsies are standard of care for transplant surveillance,
however the procedural risks are not well established, especially in children. The purpose of …

Pediatric heart failure and transplantation carry associated risks for kidney failure and
potential need for kidney transplant following pediatric heart transplantation (KT/pHT). This …

Background There are limited data evaluating the success of a structured transition plan
specifically for pediatric heart transplant (HT) recipients following their transfer of care to an …

Aims Heart transplantation is a well‐established treatment for end‐stage heart failure in
paediatric patients, demonstrating excellent long‐term outcomes. Methods This …

Background Troponin I is a blood biomarker of cardiac injury and levels measured using a
high‐sensitivity assay after pediatric heart transplantation (HT) have not been described. We …

Introduction The aim of this study was to analyze the results after pediatric heart
transplantation (pHTx) at our single center differentiating between ABO-incompatible (ABOi) …

Background Despite considerable progress in heart transplantation, pediatric waiting list
mortality is still high, and often patients do not have enough time to wait. We hypothesized …